AU780185B2 - Global regulators of bacterial pathogenic genes; bacterial autoinducer inactivation protein, as targets for engineering disease resistance - Google Patents
Global regulators of bacterial pathogenic genes; bacterial autoinducer inactivation protein, as targets for engineering disease resistance Download PDFInfo
- Publication number
- AU780185B2 AU780185B2 AU15948/00A AU1594800A AU780185B2 AU 780185 B2 AU780185 B2 AU 780185B2 AU 15948/00 A AU15948/00 A AU 15948/00A AU 1594800 A AU1594800 A AU 1594800A AU 780185 B2 AU780185 B2 AU 780185B2
- Authority
- AU
- Australia
- Prior art keywords
- nucleic acid
- bacterial
- protein
- plant
- autoinducer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 108090000623 proteins and genes Proteins 0.000 title claims description 101
- 102000004169 proteins and genes Human genes 0.000 title claims description 70
- 230000002779 inactivation Effects 0.000 title claims description 50
- 230000001580 bacterial effect Effects 0.000 title claims description 48
- 208000035240 Disease Resistance Diseases 0.000 title claims description 8
- 230000001717 pathogenic effect Effects 0.000 title description 12
- 241000196324 Embryophyta Species 0.000 claims description 50
- 150000007523 nucleic acids Chemical class 0.000 claims description 50
- 108020004707 nucleic acids Proteins 0.000 claims description 37
- 102000039446 nucleic acids Human genes 0.000 claims description 37
- 238000000034 method Methods 0.000 claims description 36
- 230000000694 effects Effects 0.000 claims description 31
- 241001465754 Metazoa Species 0.000 claims description 22
- 201000010099 disease Diseases 0.000 claims description 15
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 15
- 230000014509 gene expression Effects 0.000 claims description 15
- 230000001018 virulence Effects 0.000 claims description 13
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 12
- 239000000284 extract Substances 0.000 claims description 12
- 241000588724 Escherichia coli Species 0.000 claims description 11
- 244000061456 Solanum tuberosum Species 0.000 claims description 9
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 9
- 230000008827 biological function Effects 0.000 claims description 9
- 230000006870 function Effects 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 9
- 238000012216 screening Methods 0.000 claims description 9
- 230000001105 regulatory effect Effects 0.000 claims description 8
- 235000010149 Brassica rapa subsp chinensis Nutrition 0.000 claims description 7
- 235000000536 Brassica rapa subsp pekinensis Nutrition 0.000 claims description 7
- 241000499436 Brassica rapa subsp. pekinensis Species 0.000 claims description 7
- 230000006378 damage Effects 0.000 claims description 7
- 240000007087 Apium graveolens Species 0.000 claims description 6
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 claims description 6
- 235000010591 Appio Nutrition 0.000 claims description 6
- 244000000626 Daucus carota Species 0.000 claims description 6
- 235000002767 Daucus carota Nutrition 0.000 claims description 6
- 230000002255 enzymatic effect Effects 0.000 claims description 6
- 239000013604 expression vector Substances 0.000 claims description 6
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 5
- 108010076504 Protein Sorting Signals Proteins 0.000 claims description 5
- 244000061458 Solanum melongena Species 0.000 claims description 5
- 235000002597 Solanum melongena Nutrition 0.000 claims description 5
- 108091026890 Coding region Proteins 0.000 claims description 4
- 235000019750 Crude protein Nutrition 0.000 claims description 4
- 230000001965 increasing effect Effects 0.000 claims description 4
- 230000002265 prevention Effects 0.000 claims description 4
- 230000009467 reduction Effects 0.000 claims description 4
- 239000002689 soil Substances 0.000 claims description 4
- 238000009396 hybridization Methods 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- 208000035143 Bacterial infection Diseases 0.000 claims description 2
- 241000206602 Eukaryota Species 0.000 claims description 2
- 208000022362 bacterial infectious disease Diseases 0.000 claims description 2
- 239000012528 membrane Substances 0.000 claims description 2
- 239000000523 sample Substances 0.000 claims description 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 3
- 235000018102 proteins Nutrition 0.000 description 58
- 241000588701 Pectobacterium carotovorum Species 0.000 description 27
- 101150020252 aiiA gene Proteins 0.000 description 22
- 241000894006 Bacteria Species 0.000 description 14
- 210000004027 cell Anatomy 0.000 description 13
- 101000716809 Homo sapiens Secretogranin-1 Proteins 0.000 description 12
- 102100020867 Secretogranin-1 Human genes 0.000 description 12
- 238000004166 bioassay Methods 0.000 description 12
- 238000004519 manufacturing process Methods 0.000 description 12
- YRYOXRMDHALAFL-UHFFFAOYSA-N OHHL Natural products CCCC(=O)CC(=O)NC1CCOC1=O YRYOXRMDHALAFL-UHFFFAOYSA-N 0.000 description 11
- 150000001413 amino acids Chemical group 0.000 description 11
- 108020004414 DNA Proteins 0.000 description 10
- 102000004190 Enzymes Human genes 0.000 description 9
- 108090000790 Enzymes Proteins 0.000 description 9
- 230000027455 binding Effects 0.000 description 9
- 230000033228 biological regulation Effects 0.000 description 9
- 229940088598 enzyme Drugs 0.000 description 9
- 102000004580 Aspartic Acid Proteases Human genes 0.000 description 8
- 108010017640 Aspartic Acid Proteases Proteins 0.000 description 8
- 108700026244 Open Reading Frames Proteins 0.000 description 8
- 244000052616 bacterial pathogen Species 0.000 description 8
- 238000012217 deletion Methods 0.000 description 8
- 230000037430 deletion Effects 0.000 description 8
- 241000607620 Aliivibrio fischeri Species 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 7
- 239000002773 nucleotide Substances 0.000 description 7
- 125000003729 nucleotide group Chemical group 0.000 description 7
- 210000001519 tissue Anatomy 0.000 description 7
- 241000588698 Erwinia Species 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 239000012634 fragment Substances 0.000 description 6
- 241000194110 Bacillus sp. (in: Bacteria) Species 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 108090000765 processed proteins & peptides Proteins 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 4
- 241000589516 Pseudomonas Species 0.000 description 4
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 238000010367 cloning Methods 0.000 description 4
- 239000013601 cosmid vector Substances 0.000 description 4
- 239000002054 inoculum Substances 0.000 description 4
- 239000003446 ligand Substances 0.000 description 4
- 238000004020 luminiscence type Methods 0.000 description 4
- 230000007918 pathogenicity Effects 0.000 description 4
- 239000013612 plasmid Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000012163 sequencing technique Methods 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 238000011144 upstream manufacturing Methods 0.000 description 4
- 108700028369 Alleles Proteins 0.000 description 3
- 241000798734 Archaeorhizomycetes Species 0.000 description 3
- 230000004568 DNA-binding Effects 0.000 description 3
- 241000588700 Dickeya chrysanthemi Species 0.000 description 3
- 244000061176 Nicotiana tabacum Species 0.000 description 3
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 3
- 241000932831 Pantoea stewartii Species 0.000 description 3
- 241000589636 Xanthomonas campestris Species 0.000 description 3
- 241000607735 Xenorhabdus nematophila Species 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 238000012512 characterization method Methods 0.000 description 3
- 230000021615 conjugation Effects 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 230000029279 positive regulation of transcription, DNA-dependent Effects 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- RNAMYOYQYRYFQY-UHFFFAOYSA-N 2-(4,4-difluoropiperidin-1-yl)-6-methoxy-n-(1-propan-2-ylpiperidin-4-yl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine Chemical compound N1=C(N2CCC(F)(F)CC2)N=C2C=C(OCCCN3CCCC3)C(OC)=CC2=C1NC1CCN(C(C)C)CC1 RNAMYOYQYRYFQY-UHFFFAOYSA-N 0.000 description 2
- 241000589158 Agrobacterium Species 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 2
- QJPWUUJVYOJNMH-VKHMYHEASA-N L-homoserine lactone Chemical group N[C@H]1CCOC1=O QJPWUUJVYOJNMH-VKHMYHEASA-N 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 241000589540 Pseudomonas fluorescens Species 0.000 description 2
- MEFKEPWMEQBLKI-AIRLBKTGSA-N S-adenosyl-L-methioninate Chemical compound O[C@@H]1[C@H](O)[C@@H](C[S+](CC[C@H](N)C([O-])=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 MEFKEPWMEQBLKI-AIRLBKTGSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 108091081024 Start codon Proteins 0.000 description 2
- 239000004098 Tetracycline Substances 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 238000005415 bioluminescence Methods 0.000 description 2
- 230000029918 bioluminescence Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 210000004899 c-terminal region Anatomy 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 150000002596 lactones Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000013011 mating Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 239000002808 molecular sieve Substances 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 244000000003 plant pathogen Species 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 230000018612 quorum sensing Effects 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 229960002180 tetracycline Drugs 0.000 description 2
- 229930101283 tetracycline Natural products 0.000 description 2
- 235000019364 tetracycline Nutrition 0.000 description 2
- 150000003522 tetracyclines Chemical class 0.000 description 2
- 238000001890 transfection Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 241001430294 unidentified retrovirus Species 0.000 description 2
- 239000013598 vector Substances 0.000 description 2
- UKAUYVFTDYCKQA-UHFFFAOYSA-N -2-Amino-4-hydroxybutanoic acid Natural products OC(=O)C(N)CCO UKAUYVFTDYCKQA-UHFFFAOYSA-N 0.000 description 1
- 108020004465 16S ribosomal RNA Proteins 0.000 description 1
- FXCMGCFNLNFLSH-JTQLQIEISA-N 3-oxo-octanoic acid (2-oxo-tetrahydro-furan-3-yl)-amide Chemical compound CCCCCC(=O)CC(=O)N[C@H]1CCOC1=O FXCMGCFNLNFLSH-JTQLQIEISA-N 0.000 description 1
- 108091005508 Acid proteases Proteins 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 244000291564 Allium cepa Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 101000686977 Arabidopsis thaliana Pathogenesis-related protein 5 Proteins 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- 235000002568 Capsicum frutescens Nutrition 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 102100035882 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 108091035707 Consensus sequence Proteins 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 241001303048 Ditta Species 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 108010059378 Endopeptidases Proteins 0.000 description 1
- 102000005593 Endopeptidases Human genes 0.000 description 1
- 241000588921 Enterobacteriaceae Species 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- 108010070675 Glutathione transferase Proteins 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- 235000003228 Lactuca sativa Nutrition 0.000 description 1
- 108060001084 Luciferase Proteins 0.000 description 1
- 239000005089 Luciferase Substances 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 101100476800 Mus musculus Chgb gene Proteins 0.000 description 1
- 241000231286 Neottia Species 0.000 description 1
- KYGIKEQVUKTKRR-UHFFFAOYSA-N ODHL Natural products CCCCCCCC(=O)CC(=O)NC1CCOC1=O KYGIKEQVUKTKRR-UHFFFAOYSA-N 0.000 description 1
- FXCMGCFNLNFLSH-UHFFFAOYSA-N OOHL Natural products CCCCCC(=O)CC(=O)NC1CCOC1=O FXCMGCFNLNFLSH-UHFFFAOYSA-N 0.000 description 1
- 206010034133 Pathogen resistance Diseases 0.000 description 1
- 108010047320 Pepsinogen A Proteins 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108010059820 Polygalacturonase Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 241001645955 Pseudomonas chlororaphis subsp. aureofaciens Species 0.000 description 1
- 241000589612 Pseudomonas savastanoi pv. glycinea Species 0.000 description 1
- 241000589623 Pseudomonas syringae pv. syringae Species 0.000 description 1
- 241000232299 Ralstonia Species 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 108700008625 Reporter Genes Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000607720 Serratia Species 0.000 description 1
- 241000589196 Sinorhizobium meliloti Species 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 108020005038 Terminator Codon Proteins 0.000 description 1
- 108700009124 Transcription Initiation Site Proteins 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 241000607598 Vibrio Species 0.000 description 1
- 241000607618 Vibrio harveyi Species 0.000 description 1
- 241000589634 Xanthomonas Species 0.000 description 1
- 101100543997 Yersinia enterocolitica yenR gene Proteins 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 229960001570 ademetionine Drugs 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 238000004873 anchoring Methods 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N aspartic acid group Chemical group N[C@@H](CC(=O)O)C(=O)O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- 230000000680 avirulence Effects 0.000 description 1
- 238000002869 basic local alignment search tool Methods 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000032770 biofilm formation Effects 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 108010079058 casein hydrolysate Proteins 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 230000008568 cell cell communication Effects 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 229940106157 cellulase Drugs 0.000 description 1
- 239000013599 cloning vector Substances 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000012866 crystallographic experiment Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 229940066758 endopeptidases Drugs 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 108010093305 exopolygalacturonase Proteins 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000001723 extracellular space Anatomy 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- -1 flavorings Substances 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000003209 gene knockout Methods 0.000 description 1
- 238000012239 gene modification Methods 0.000 description 1
- 108091006104 gene-regulatory proteins Proteins 0.000 description 1
- 102000034356 gene-regulatory proteins Human genes 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 230000005017 genetic modification Effects 0.000 description 1
- 238000012248 genetic selection Methods 0.000 description 1
- 230000007614 genetic variation Effects 0.000 description 1
- 235000013617 genetically modified food Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000000710 homodimer Substances 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 230000016784 immunoglobulin production Effects 0.000 description 1
- 229940072221 immunoglobulins Drugs 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 101150066555 lacZ gene Proteins 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 101150040799 luxI gene Proteins 0.000 description 1
- 101150016512 luxR gene Proteins 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- YBTWUESFQWFDMR-UHFFFAOYSA-N methyl 3-hydroxypalmitate Chemical compound CCCCCCCCCCCCCC(O)CC(=O)OC YBTWUESFQWFDMR-UHFFFAOYSA-N 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 230000000869 mutational effect Effects 0.000 description 1
- 210000004897 n-terminal region Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000012457 nonaqueous media Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000008659 phytopathology Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000004043 responsiveness Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000010845 search algorithm Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000005174 swarming motility Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000012049 topical pharmaceutical composition Substances 0.000 description 1
- 101150113807 traR gene Proteins 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 108091006106 transcriptional activators Proteins 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- 239000000304 virulence factor Substances 0.000 description 1
- 230000007923 virulence factor Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SG9903146A SG91822A1 (en) | 1999-07-02 | 1999-07-02 | Global regulators of bacterial pathogenic genes as targets for engineering disease resistance |
| SG9903146 | 1999-07-02 | ||
| PCT/SG1999/000128 WO2001002578A1 (en) | 1999-07-02 | 1999-11-17 | Global regulators of bacterial pathogenic genes; bacterial autoinducer inactivation protein, as targets for engineering disease resistance |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU1594800A AU1594800A (en) | 2001-01-22 |
| AU780185B2 true AU780185B2 (en) | 2005-03-03 |
Family
ID=20430385
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU15948/00A Ceased AU780185B2 (en) | 1999-07-02 | 1999-11-17 | Global regulators of bacterial pathogenic genes; bacterial autoinducer inactivation protein, as targets for engineering disease resistance |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US7309814B1 (https=) |
| EP (1) | EP1192256B1 (https=) |
| JP (1) | JP4514381B2 (https=) |
| CN (1) | CN1230539C (https=) |
| AP (1) | AP2003002803A0 (https=) |
| AT (1) | ATE305042T1 (https=) |
| AU (1) | AU780185B2 (https=) |
| BR (1) | BR9917419A (https=) |
| CA (1) | CA2378153A1 (https=) |
| DE (1) | DE69927416T2 (https=) |
| HU (1) | HUP0202166A3 (https=) |
| IL (2) | IL147334A0 (https=) |
| MX (1) | MXPA02000263A (https=) |
| MY (1) | MY136784A (https=) |
| NO (1) | NO20016397L (https=) |
| NZ (1) | NZ516516A (https=) |
| RU (1) | RU2236462C2 (https=) |
| SG (1) | SG91822A1 (https=) |
| TR (1) | TR200103820T2 (https=) |
| WO (1) | WO2001002578A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7410638B1 (en) * | 2000-08-23 | 2008-08-12 | Institute Of Molecular Agrobiology | Bacterial strains, genes and enzymes for control of bacterial diseases by quenching quorum-sensing signals |
| EP1358340A1 (en) | 2001-01-29 | 2003-11-05 | Institute of Molecular Agrobiology | Control of bacterial infection by quenching quorum-sensing of plant pathogenic bacteria |
| GB0326194D0 (en) * | 2003-11-10 | 2003-12-17 | Univ Kent Canterbury | Proteins involved in signal transduction |
| EP1967196A4 (en) | 2005-11-18 | 2009-10-14 | Idemitsu Kosan Co | BACILLUS THURINGIENSIS CONTAINING MEANS FOR THE CONTROL OF HARMFUL BACTERIA |
| BR102015026078A2 (pt) * | 2015-10-14 | 2017-05-16 | Inst Agronômico Do Paraná - Iapar | Method for production of transgenic plants and plants with resistance to bacteria that have the quorum sensing system |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5639949A (en) | 1990-08-20 | 1997-06-17 | Ciba-Geigy Corporation | Genes for the synthesis of antipathogenic substances |
| US5591872A (en) * | 1993-08-09 | 1997-01-07 | The University Of Iowa Research Foundation | Autoinducer molecule |
| US5993827A (en) * | 1993-09-10 | 1999-11-30 | The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins |
| AUPN191295A0 (en) * | 1995-03-23 | 1995-04-27 | Unisearch Limited | Microbiocide or microbial regulator |
| US5759798A (en) * | 1995-12-08 | 1998-06-02 | Woods Hole Oceanographic Institution | Assays, test kits and bacteria for detection of autoinducers |
| DE19548301C1 (de) * | 1995-12-22 | 1997-02-27 | Klaus Dr Duering | Inhibition von Signalmolekülen durch bindende oder katalytische Antikörper |
| EP0994961B1 (en) * | 1997-06-18 | 2006-10-18 | Montana State University - Bozeman | Homoserine lactones biofilm regulating compounds and their methods of use |
| US20050244935A1 (en) * | 1999-06-25 | 2005-11-03 | Basf Ag | Corynebacterium glutamicum genes encoding proteins involved in membrane synthesis and membrane transport |
| CA2383743A1 (en) * | 1999-09-03 | 2001-03-15 | The University Of Iowa Research Foundation | Quorum sensing signaling in bacteria |
| US7410638B1 (en) * | 2000-08-23 | 2008-08-12 | Institute Of Molecular Agrobiology | Bacterial strains, genes and enzymes for control of bacterial diseases by quenching quorum-sensing signals |
| EP1358340A1 (en) * | 2001-01-29 | 2003-11-05 | Institute of Molecular Agrobiology | Control of bacterial infection by quenching quorum-sensing of plant pathogenic bacteria |
| AU2002225585A1 (en) * | 2002-01-23 | 2003-09-04 | Agency For Science, Technology And Research | Ralstonia ahl-acylase gene |
| US7335352B1 (en) * | 2003-06-04 | 2008-02-26 | California Institute Of Technology | Method of identifying agents that inhibit quorum sensing activity of gamma-proteobacteria |
-
1999
- 1999-07-02 SG SG9903146A patent/SG91822A1/en unknown
- 1999-11-17 US US10/019,661 patent/US7309814B1/en not_active Expired - Fee Related
- 1999-11-17 CN CNB998167894A patent/CN1230539C/zh not_active Expired - Fee Related
- 1999-11-17 DE DE69927416T patent/DE69927416T2/de not_active Expired - Lifetime
- 1999-11-17 EP EP99958619A patent/EP1192256B1/en not_active Expired - Lifetime
- 1999-11-17 NZ NZ516516A patent/NZ516516A/en not_active IP Right Cessation
- 1999-11-17 MX MXPA02000263A patent/MXPA02000263A/es unknown
- 1999-11-17 AP APAP/P/2003/002803A patent/AP2003002803A0/en unknown
- 1999-11-17 JP JP2001508350A patent/JP4514381B2/ja not_active Expired - Fee Related
- 1999-11-17 TR TR2001/03820T patent/TR200103820T2/xx unknown
- 1999-11-17 RU RU2002102558/13A patent/RU2236462C2/ru not_active IP Right Cessation
- 1999-11-17 CA CA002378153A patent/CA2378153A1/en not_active Abandoned
- 1999-11-17 IL IL14733499A patent/IL147334A0/xx unknown
- 1999-11-17 AU AU15948/00A patent/AU780185B2/en not_active Ceased
- 1999-11-17 AT AT99958619T patent/ATE305042T1/de not_active IP Right Cessation
- 1999-11-17 HU HU0202166A patent/HUP0202166A3/hu unknown
- 1999-11-17 BR BR9917419-7A patent/BR9917419A/pt not_active IP Right Cessation
- 1999-11-17 WO PCT/SG1999/000128 patent/WO2001002578A1/en not_active Ceased
-
2000
- 2000-05-19 MY MYPI20002206A patent/MY136784A/en unknown
-
2001
- 2001-12-26 IL IL147334A patent/IL147334A/en not_active IP Right Cessation
- 2001-12-27 NO NO20016397A patent/NO20016397L/no unknown
-
2007
- 2007-08-01 US US11/832,497 patent/US20080161238A1/en not_active Abandoned
Non-Patent Citations (1)
| Title |
|---|
| HWANG ET AL. J BACTERIOL 1995 177(2):449-458 * |
Also Published As
| Publication number | Publication date |
|---|---|
| BR9917419A (pt) | 2002-04-02 |
| EP1192256B1 (en) | 2005-09-21 |
| DE69927416D1 (de) | 2006-02-02 |
| SG91822A1 (en) | 2002-10-15 |
| JP4514381B2 (ja) | 2010-07-28 |
| DE69927416T2 (de) | 2006-06-29 |
| AU1594800A (en) | 2001-01-22 |
| RU2002102558A (ru) | 2004-02-27 |
| MXPA02000263A (es) | 2003-09-25 |
| HUP0202166A2 (hu) | 2002-11-28 |
| US20080161238A1 (en) | 2008-07-03 |
| TR200103820T2 (tr) | 2002-05-21 |
| CN1361823A (zh) | 2002-07-31 |
| RU2236462C2 (ru) | 2004-09-20 |
| WO2001002578A1 (en) | 2001-01-11 |
| ATE305042T1 (de) | 2005-10-15 |
| AP2003002803A0 (en) | 2003-06-30 |
| IL147334A0 (en) | 2002-08-14 |
| NZ516516A (en) | 2004-10-29 |
| JP2003504028A (ja) | 2003-02-04 |
| US7309814B1 (en) | 2007-12-18 |
| NO20016397D0 (no) | 2001-12-27 |
| EP1192256A1 (en) | 2002-04-03 |
| CN1230539C (zh) | 2005-12-07 |
| NO20016397L (no) | 2002-02-21 |
| CA2378153A1 (en) | 2001-01-11 |
| IL147334A (en) | 2010-05-17 |
| MY136784A (en) | 2008-11-28 |
| HUP0202166A3 (en) | 2005-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Andersson et al. | Quorum sensing in the plant pathogen Erwinia carotovora subsp. carotovora: the role of expREcc | |
| Zou et al. | Elucidation of the hrp clusters of Xanthomonas oryzae pv. oryzicola that control the hypersensitive response in nonhost tobacco and pathogenicity in susceptible host rice | |
| Milton et al. | Quorum sensing in Vibrio anguillarum: characterization of the vanI/vanR locus and identification of the autoinducer N-(3-oxodecanoyl)-L-homoserine lactone | |
| Pirhonen et al. | A small diffusible signal molecule is responsible for the global control of virulence and exoenzyme production in the plant pathogen Erwinia carotovora. | |
| Cui et al. | Effects of the two-component system comprising GacA and GacS of Erwinia carotovora subsp. carotovora on the production of global regulatory rsmB RNA, extracellular enzymes, and harpinEcc | |
| Hossain et al. | Motility is an important determinant for pathogenesis of Erwinia carotovora subsp. carotovora | |
| Strano et al. | P seudomonas corrugata crpCDE is part of the cyclic lipopeptide corpeptin biosynthetic gene cluster and is involved in bacterial virulence in tomato and in hypersensitive response in N icotiana benthamiana | |
| Tian et al. | Type VI secretion systems of Erwinia amylovora contribute to bacterial competition, virulence, and exopolysaccharide production | |
| US7888493B2 (en) | Bacterial strains, genes and enzymes for control of bacterial diseases by quenching quorum-sensing signals | |
| Meyer et al. | PopF1 and PopF2, two proteins secreted by the type III protein secretion system of Ralstonia solanacearum, are translocators belonging to the HrpF/NopX family | |
| US20080161238A1 (en) | Nucleic acid molecules encoding bacterial autoinducer inactivation proteins as targets for engineering disease resistance | |
| Kresse et al. | Pas, a novel protein required for protein secretion and attaching and effacing activities of enterohemorrhagic Escherichia coli | |
| Asselin et al. | Eop1 from a Rubus strain of Erwinia amylovora functions as a host-range limiting factor | |
| Zang et al. | Requirement of a mip-like gene for virulence in the phytopathogenic bacterium Xanthomonas campestris pv. campestris | |
| Clarke et al. | The gene coding for polynucleotide phosphorylase in Photorhabdus sp. strain K122 is induced at low temperatures | |
| KIM et al. | Comparative analysis of the XopD type III secretion (T3S) effector family in plant pathogenic bacteria | |
| AU2000276976A1 (en) | Bacterial strains, genes and enzymes for control of bacterial diseases by quenching quorum-sensing signals | |
| KR100741949B1 (ko) | 세균의 병원성 유전자의 광범위한 조절물질； 질병저항성을 도모하기 위한 표적으로서, 세균의 자가유도물질불활성화 단백질 | |
| Hutcheson et al. | Regulation and detection of effectors translocated by Pseudomonas syringae | |
| Venturi et al. | Involvement of | |
| EP1930440A1 (en) | Bacterial Strains, Genes and Enzymes for Control of Bacterial Diseases by Quenching Quorum-Sensing Signals | |
| Pemberton et al. | Chemical signalling by bacterial plant pathogens | |
| Zhang et al. | Identification of Quorum-Quenching | |
| Podile et al. | MOLECULAR GENETICS OF'MOB-ATTACK'BY PHYTOPATHOGENIC | |
| Paredes | Interkingdom Signalling Via a LuxR-family Protein in Plant Associated Bacteria |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase | ||
| TH | Corrigenda |
Free format text: IN VOL 15, NO 17, PAGE(S) 3594-3598 UNDER THE HEADING APPLICATIONS LAPSED, REFUSED OR WITHDRAWN PLEASE DELETE ALL REFERENCE TO APPLICATION NO. 15948/00 AND 62667/00 |